Cargando…
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
Engineered cytokine products represent a growing class of therapeutic proteins which need to be tested for biological activity at various stages of pharmaceutical development. In most cases, dedicated biological assays are established for different products, in a process that can be time-consuming a...
Autores principales: | Mock, Jacqueline, Pellegrino, Christian, Neri, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040017/ https://www.ncbi.nlm.nih.gov/pubmed/32094407 http://dx.doi.org/10.1038/s41598-020-60182-4 |
Ejemplares similares
-
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors
por: Mortensen, Michael R., et al.
Publicado: (2020) -
Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression
por: Stringhini, Marco, et al.
Publicado: (2021) -
Engineering Protocells: Prospects for Self-Assembly and Nanoscale Production-Lines
por: Miller, David M., et al.
Publicado: (2015) -
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties
por: Di Nitto, Cesare, et al.
Publicado: (2023) -
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease
por: Dakhel, Sheila, et al.
Publicado: (2021)